These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 21173408)

  • 21. ACP Journal Club is dead...long live ACP Journal Club.
    Haynes RB
    ACP J Club; 2008; 148(2):A8. PubMed ID: 18311857
    [No Abstract]   [Full Text] [Related]  

  • 22. ACP Journal Club. Increased frequency of hemodialysis reduced adverse clinical outcomes.
    Nesrallah GE
    Ann Intern Med; 2011 Apr; 154(8):JC4-6. PubMed ID: 21502644
    [No Abstract]   [Full Text] [Related]  

  • 23. ACP Journal Club. Simple models predicted 10-year fracture risk in older women as accurately as more complex FRAX models.
    Kauffman RP
    Ann Intern Med; 2010 Mar; 152(6):JC3-13. PubMed ID: 20231555
    [No Abstract]   [Full Text] [Related]  

  • 24. ACP Journal Club. Review: Exercise/physical therapy and vitamin D each reduce risk for falls in older community-dwelling adults.
    Kiel DP
    Ann Intern Med; 2011 Apr; 154(8):JC4-5. PubMed ID: 21502643
    [No Abstract]   [Full Text] [Related]  

  • 25. ACP Journal Club. Review: Erythropoiesis-stimulating agents targeted to higher hemoglobin levels increase risk for adverse outcomes in CKD.
    Hsu CY
    Ann Intern Med; 2010 Nov; 153(10):JC5-3. PubMed ID: 21079210
    [No Abstract]   [Full Text] [Related]  

  • 26. ACP Journal Club. Review: Tamoxifen, raloxifene, and tibolone prevent primary invasive breast cancer but increase risk for adverse outcomes.
    Melnikow J
    Ann Intern Med; 2010 Mar; 152(6):JC3-4. PubMed ID: 20231558
    [No Abstract]   [Full Text] [Related]  

  • 27. ACP Journal Club. Simvastatin reduced major vascular events at 5 years in at-risk patients; benefits were maintained at 11 years.
    Havranek EP
    Ann Intern Med; 2012 Mar; 156(6):JC3-5. PubMed ID: 22431691
    [No Abstract]   [Full Text] [Related]  

  • 28. ACP Journal Club: a single, annual, high dose of oral vitamin D increased falls and fractures in older women.
    Sanders K
    Ann Intern Med; 2010 Sep; 153(6):JC3-3. PubMed ID: 20855792
    [No Abstract]   [Full Text] [Related]  

  • 29. ACP journal club. Cognitive-behavioral therapy reduced risk for recurrence in patients recently hospitalized with cardiovascular disease events.
    Thase ME
    Ann Intern Med; 2011 May; 154(10):JC5-04. PubMed ID: 21576522
    [No Abstract]   [Full Text] [Related]  

  • 30. ACP Journal Club. Editorial: new and underutilized features of ACP Journal Club PLUS and ACPJC.org: stellar articles, searches, and succinct synopses of the principles and practice of "personalized" evidence-based medicine.
    Haynes B
    Ann Intern Med; 2009 Dec; 151(12):JC6-2, JC6-3. PubMed ID: 20008752
    [No Abstract]   [Full Text] [Related]  

  • 31. ACP Journal Club. Increased doses of clopidogrel or aspirin did not prevent cardiovascular events.
    Moliterno DJ
    Ann Intern Med; 2011 Jan; 154(2):JC1-7. PubMed ID: 21242361
    [No Abstract]   [Full Text] [Related]  

  • 32. ACP Journal Club. Darbepoetin decreased transfusions and fatigue, but increased adverse effects in patients with chronic kidney disease, diabetes, and anemia.
    Patel TV
    Ann Intern Med; 2010 Mar; 152(6):JC3-9. PubMed ID: 20231563
    [No Abstract]   [Full Text] [Related]  

  • 33. ACP Journal Club. 2 or more medical errors with adverse consequences, affecting 2.6% of patients, increased mortality in intensive care units.
    Dodek P
    Ann Intern Med; 2010 May; 152(10):JC5-12. PubMed ID: 20479017
    [No Abstract]   [Full Text] [Related]  

  • 34. ACP Journal Club. Daily n-3 fatty acid supplements did not reduce CV events in high-risk patients with dysglycemia.
    Lader E
    Ann Intern Med; 2012 Sep; 157(6):JC3-11. PubMed ID: 22986403
    [No Abstract]   [Full Text] [Related]  

  • 35. ACP Journal Club. Valsartan reduced diabetes but not CV events in patients with impaired glucose tolerance and CV risk factors.
    Ann Intern Med; 2010 Jun; 152(12):JC6-9. PubMed ID: 20547903
    [No Abstract]   [Full Text] [Related]  

  • 36. ACP Journal Club. Nateglinide did not reduce diabetes or CV events in patients with impaired glucose tolerance and CV risk factors.
    Farkouh M
    Ann Intern Med; 2010 Jun; 152(12):JC6-10. PubMed ID: 20547892
    [No Abstract]   [Full Text] [Related]  

  • 37. ACP Journal Club. Meta-analysis: lowering LDL-C levels using statins reduces major vascular events regardless of baseline risk.
    Jain M; Rosenberg M
    Ann Intern Med; 2012 Oct; 157(8):JC4-2. PubMed ID: 23070504
    [No Abstract]   [Full Text] [Related]  

  • 38. ACP journal club. Intensive glucose control increased mortality and did not prevent CV events compared with standard glucose control in type 2 diabetes.
    Grubina R; Smith SA
    Ann Intern Med; 2011 May; 154(10):JC5-02. PubMed ID: 21576520
    [No Abstract]   [Full Text] [Related]  

  • 39. ACP Journal Club. Adding omeprazole to clopidogrel reduced GI events and did not increase CV events.
    Chow CK
    Ann Intern Med; 2011 Mar; 154(6):JC3-7. PubMed ID: 21403070
    [No Abstract]   [Full Text] [Related]  

  • 40. ACP Journal Club. Hypnotic drugs were associated with increased risk for mortality.
    Levine M
    Ann Intern Med; 2012 Jun; 156(12):JC6-13. PubMed ID: 22711114
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.